The KRAS and Cell cycle pathways were also highly enriched in early mutations, RTK/KRAS in 7 metastatic and 4 primary cancer types, and Cell cycle in 6 metastatic and 2 primary cancer types (Figure 4C). The gene discussed is KRAS; the disease is cancer.